Tani, Mami
Yamaguchi, Tomofumi
Honaga, Kaoru
Takahashi, Yoko
Kono, Hidemi
Murakami, Yuhei
Isayama, Reina
Haruyama, Koshiro
Fujino, Yuji
Matsuda, Tadamitsu
Fukunaga, Issei
Hori, Masaaki
Tanuma, Akira
Wada, Futoshi
Hatori, Kozo
Fujiwara, Toshiyuki
Funding for this research was provided by:
JSPS KAKENHI (26350587)
Article History
Received: 10 March 2025
Accepted: 1 July 2025
First Online: 7 July 2025
Declarations
:
: This study was approved by the Juntendo University Hospital Ethics Committee (CRB3180012) and was registered in the Japan Registry of Clinical Trial (JRCT registration ID: jRCTs032180289). All participants provided written informed consent according to the protocol approved by the local institutional review board. The study was performed according to the Declaration of Helsinki.
: All authors have agreed to publication.
: TF has Grants or contracts from Meltin MMI, LIFESCAPE Inc., I3 MEDICAL Inc., Meteo Inc., Takashimaya Co., Ltd., MF Consultant Co. Ltd., JF rehabilitation clinic, The MIKIYA Science and Technology Foundation, Pacific Supply Co., Ltd. and Patents (Japan 6751881, USA 10,668,281 China ZL201680015103, Japan 5224510). TF has honoraria for lectures from TEIJIN HEALTHCARE Limited, GlaxoSmithKline plc., MFC Medical Co., Ltd., Daiichi Sankyo Co., Ltd., FrontAct Co., Ltd., LIFESCAPE Inc.